The antimicrobial stewardship virtual professional group is chaired by Sajida Khatri and Elizabeth Beech. Sign up for the group and view previous recordings here and then link to https://www.prescqipp.info/community-resources/virtual-professional-groups/antimicrobial-stewardship/
The next AMS VPG and Continence and stoma VPG webinar will take place on Wednesday 11th March, 1-2pm.
Urinary Tract Infection and urinary catheter prescribing in primary and community care – introducing 3 new data dashboards to support population health
We will be demonstrating the new UTI and catheter device prescribing dashboard. Therefore, we are combining the AMS VPG and Continence and stoma VPG into one meeting so we can demonstrate this to everyone together.
The 3 Urinary Tract Infection Dashboards report population exposure via FP10 prescription to urinary catheter devices, methenamine and specific antibiotics included in NICE guidance for the treatment of urinary tract infections - uncomplicated, complicated, and recurrent infection. These dashboards use routine FP10 prescribing data accessed from NHSBSA ePACT2 analysis and use metrics reporting the count of unique patients, linking patient data over time.
Combatting antimicrobial resistance – the UK second five-year national action plan https://www.gov.uk/government/publications/uk-5-year-action-plan-for-antimicrobial-resistance-2024-to-2029 continues to promote optimal use of antimicrobials in humans to ensure safe and effective patient care by strengthening antimicrobial stewardship programmes which should include the review of choice and duration of antimicrobial prescriptions.
It includes an ambition to reduce UK antimicrobial use in humans by 5% by 2029, and to prevent any increase in Gram-negative bloodstream infections. These infections are commonly associated with urinary tract infection and use of urinary catheter devices. Optimising the management of urinary tract infection and the use of urinary catheter devices can reduce unnecessary antibiotic treatment and associated risk of development of antimicrobial resistance. Optimising the choice and duration of antibiotic use supports delivery of these key requirements, and NICE publish antimicrobial stewardship guidance https://www.nice.org.uk/guidance/health-protection/communicable-diseases/antimicrobial-stewardship that provides evidence based recommendations for choice and duration of antibiotic use to treat urinary tract infections, including catheter associated urinary tract infection.
The 3 Urinary Tract Infection Dashboards report population exposure via FP10 prescription to urinary catheter devices, methenamine and specific antibiotics included in NICE guidance for the treatment of urinary tract infections - uncomplicated, complicated, and recurrent infection. These dashboards use routine FP10 prescribing data accessed from NHSBSA ePACT2 analysis and use metrics reporting the count of unique patients, linking patient data over time.
